- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SGLT2 inhibitors, dapagliflozin
Total 772 results
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2Australia, United States, Italy, Argentina, Canada, Mexico, India, Peru, Spain, Denmark, France, Singapore, Puerto Rico
-
AstraZenecaAstraZeneca, Bristol-Myers SquibbCompletedType 2 DiabetesChina, Korea, Republic of, Taiwan, India
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, Russian Federation, Spain, United States, Canada, Puerto Rico, Hungary, Peru, Romania, Poland, Germany, Czech Republic, India, Colombia, Denmark, Finland
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompleted
-
Uppsala UniversityAstraZenecaCompleted
-
Uppsala UniversityAstraZeneca; Uppsala University HospitalCompleted
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Puerto Rico
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2United States
-
Korea University Anam HospitalAstraZenecaUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2Argentina
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaBristol-Myers SquibbTerminated
-
AstraZenecaBristol-Myers SquibbCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus (T2DM)United States
-
AstraZenecaBristol-Myers SquibbTerminatedType 2 Diabetes MellitusUnited States
-
Medical University of ViennaUnknownType 2 Diabetes | Metabolically Healthy ControlsAustria
-
AstraZenecaMonash UniversityTerminated
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
AstraZenecaCompletedType 2 DiabetesUnited States, Puerto Rico, Mexico, Russian Federation, Romania, Poland, Czech Republic, United Kingdom
-
AstraZenecaWithdrawn
-
Seoul National University Bundang HospitalCompletedLaryngeal Mask Airway
-
AstraZenecaCompletedType 2 Diabetes Mellitus
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation, Romania, Poland, Czech Republic, Puerto Rico, Hungary
-
Seoul National University HospitalAstraZenecaCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Research Clinical Centre of the Russian Railways...UnknownDiabetes Mellitus | Hypoglycemic EpisodesRussian Federation
-
Canadian Network for Observational Drug Effect...Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...Completed
-
Kinderkrankenhaus auf der BultCompleted
-
Onze Lieve Vrouw HospitalCompletedRespiratory Muscles | ElectromyographyBelgium
-
Merck Sharp & Dohme LLCCompletedAnesthesia, General | Neuromuscular Blockade
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
Palacky UniversityUniversity Hospital Olomouc; Masaryk Hospital Usti nad LabemUnknownNeuromuscular BlockadeCzech Republic
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited Kingdom
-
AstraZenecaCompletedType 2 Diabetes Mellitus
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
-
Gulf Regional Research & Educational Services, LLCUnknownMechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 DiabetesDiabetes Mellitus Type 2United States
-
Ohio State University Comprehensive Cancer CenterSchwartz, Steven, PhDCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSouth Africa, Germany, Hungary, Romania, Slovakia, Switzerland, Ukraine